DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,112 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $254,011 | -72.1% | 1,098 | -71.0% | 0.08% | -47.4% |
Q2 2023 | $909,840 | +39.2% | 3,791 | +46.2% | 0.16% | +28.9% |
Q1 2023 | $653,540 | -59.7% | 2,593 | -58.7% | 0.12% | -54.0% |
Q3 2022 | $1,620,000 | -61.6% | 6,272 | -62.3% | 0.26% | -72.4% |
Q2 2022 | $4,220,000 | +1542.0% | 16,645 | +1637.5% | 0.95% | +571.8% |
Q2 2021 | $257,000 | -97.4% | 958 | -97.8% | 0.14% | -88.0% |
Q4 2020 | $9,854,000 | +807.4% | 44,360 | +465.2% | 1.19% | +201.5% |
Q1 2020 | $1,086,000 | -57.5% | 7,849 | -59.5% | 0.39% | +95.0% |
Q1 2019 | $2,556,000 | -8.9% | 19,364 | -25.0% | 0.20% | -61.5% |
Q3 2018 | $2,805,000 | -31.8% | 25,819 | -38.1% | 0.52% | -38.3% |
Q2 2018 | $4,115,000 | -36.0% | 41,701 | -36.5% | 0.85% | +9.4% |
Q1 2018 | $6,428,000 | +119.4% | 65,649 | +92.2% | 0.78% | +252.0% |
Q3 2017 | $2,930,000 | -72.4% | 34,152 | -72.8% | 0.22% | -73.3% |
Q2 2017 | $10,600,000 | +380.5% | 125,600 | +387.0% | 0.83% | +402.4% |
Q1 2017 | $2,206,000 | -30.7% | 25,791 | -36.5% | 0.16% | -16.2% |
Q3 2016 | $3,183,000 | -70.3% | 40,598 | -61.7% | 0.20% | -73.8% |
Q2 2016 | $10,709,000 | +2537.7% | 106,024 | +2376.0% | 0.75% | +1876.3% |
Q1 2016 | $406,000 | -86.9% | 4,282 | -87.1% | 0.04% | -91.3% |
Q4 2015 | $3,091,000 | -63.8% | 33,280 | -66.8% | 0.44% | -63.6% |
Q3 2015 | $8,533,000 | +728.4% | 100,137 | +732.2% | 1.20% | +754.6% |
Q2 2015 | $1,030,000 | -81.3% | 12,033 | -81.4% | 0.14% | -84.5% |
Q1 2015 | $5,507,000 | +231.9% | 64,865 | +235.1% | 0.91% | +112.9% |
Q4 2014 | $1,659,000 | -52.4% | 19,359 | -57.8% | 0.43% | -52.0% |
Q3 2014 | $3,484,000 | +7.0% | 45,855 | +10.9% | 0.89% | -15.2% |
Q2 2014 | $3,256,000 | +158.6% | 41,360 | +146.4% | 1.05% | +89.0% |
Q1 2014 | $1,259,000 | +1.6% | 16,786 | +4.6% | 0.56% | -34.6% |
Q4 2013 | $1,239,000 | +420.6% | 16,052 | +368.0% | 0.85% | +156.0% |
Q3 2013 | $238,000 | – | 3,430 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |